{"id":168181,"date":"2010-01-12T02:13:20","date_gmt":"2010-01-12T07:13:20","guid":{"rendered":"http:\/\/www.stoth.com\/2010\/01\/12\/neuralieve-brings-in-3-9m-for-non-invasive-neurological-treatments\/"},"modified":"2010-01-12T02:13:20","modified_gmt":"2010-01-12T07:13:20","slug":"neuralieve-brings-in-3-9m-for-non-invasive-neurological-treatments","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/168181","title":{"rendered":"Neuralieve brings in $3.9M for non-invasive neurological treatments"},"content":{"rendered":"

<\/p>\n

Neuralieve<\/a>, maker of a portable, non-invasive device used to treat neurological problems, particularly migraines, has brought in $3.9 million of a targeted $7.5 million round of equity, according to a filing with the SEC. Based in Sunnyvale, Calif., the company includes a managing member of MedVenture Associates<\/a> on its board of directors.<\/p>\n

<\/img><\/a>
\n<\/img><\/a><\/p>\n

\n<\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a> <\/img><\/a>\n<\/div>\n

<\/p>\n

Buy This Item: [Click here to buy this item]<\/span><\/a><\/p>\n

Read Original Article<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Neuralieve, maker of a portable, non-invasive device used to treat neurological problems, particularly migraines, has brought in $3.9 million of a targeted $7.5 million round of equity, according to a filing with the SEC. Based in Sunnyvale, Calif., the company includes a managing member of MedVenture Associates on its board of directors. Buy This Item: […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-168181","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/168181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=168181"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/168181\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=168181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=168181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=168181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}